Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Peter G. Mol, PhD
Dutch Medicines Evaluation Board, Utrecht, The Netherlands, Netherlands
Poster(s):
(027) More-EUROPA (More Effectively Using Registries) – A cross-sectional survey assessing evidence needs around the introduction of new medicines
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(098) Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults: A Retrospective Inception Cohort Study
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(190) Do efficacy results obtained from randomised controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(CSPOT28) Limited impact of Direct Healthcare Professional Communications when using optimal outcomes and appropriate study populations: a systematic review.
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(CSPOT31) Perspectives of People With Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
